Scott Dunseth Myers - Insider Trading & Ownership

Entity
Individual
Location
C/O Cascadian Therapeutics, Inc., 3101 Western Ave., Suite 600, Seattle, WA
Summary
The estimated net worth of Scott Dunseth Myers is at least $5.74M dollars as of May 28, 2024. Scott Dunseth Myers is the Chief Executive Officer, Director of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $5.45M. Scott Dunseth Myers is the Director of DYNAVAX TECHNOLOGIES CORP and owns shares of DYNAVAX TECHNOLOGIES CORP (DVAX) stock worth about $290K.
All Insider Reports
All Insider Reports

Ownership of Scott Dunseth Myers

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
VRDN Viridian Therapeutics, Inc.\DE Chief Executive Officer, Director $5.45M Apr 12, 2023
DVAX DYNAVAX TECHNOLOGIES CORP Director $290K May 23, 2024
RNAC Cartesian Therapeutics, Inc. Director Nov 13, 2023
HARP Harpoon Therapeutics, Inc. Director Mar 11, 2024
TRIL Trillium Therapeutics Inc. Director Nov 17, 2021

Insider Transactions Reported by Scott Dunseth Myers:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.